FDA inspection
Repro Lab, Inc.: FDA inspection ending Sep 17, 2014
FDA inspection 895463 · Voluntary Action Indicated (VAI) · New York, NY
Key facts
| Inspection ID | 895463 |
|---|---|
| Firm | Repro Lab, Inc. |
| FEI number | 3000974212 |
| Address | 332 E 30th St |
| City | New York |
| State | NY |
| ZIP | 10016 |
| Country | United States |
| Fiscal year | 2014 |
| Inspection end date | Sep 17, 2014 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Human Cellular, Tissue, and Gene Therapies |
| Product type | Biologics |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data